nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PTGS2—amyotrophic lateral sclerosis	0.365	1	CbGaD
Indomethacin—Proctitis—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0528	CcSEcCtD
Indomethacin—Nephritis—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0378	CcSEcCtD
Indomethacin—Disseminated intravascular coagulation—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0361	CcSEcCtD
Indomethacin—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.00988	0.0346	CcSEcCtD
Indomethacin—Thrombocytopenic purpura—Riluzole—amyotrophic lateral sclerosis	0.00785	0.0275	CcSEcCtD
Indomethacin—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.00785	0.0275	CcSEcCtD
Indomethacin—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.00739	0.0259	CcSEcCtD
Indomethacin—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00673	0.0236	CcSEcCtD
Indomethacin—PLA2G2A—tongue—amyotrophic lateral sclerosis	0.00638	0.0514	CbGeAlD
Indomethacin—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.00619	0.0217	CcSEcCtD
Indomethacin—PPARG—forelimb—amyotrophic lateral sclerosis	0.00613	0.0494	CbGeAlD
Indomethacin—Respiratory distress—Riluzole—amyotrophic lateral sclerosis	0.00579	0.0203	CcSEcCtD
Indomethacin—PPARG—hindlimb—amyotrophic lateral sclerosis	0.00552	0.0445	CbGeAlD
Indomethacin—PTGR2—embryo—amyotrophic lateral sclerosis	0.00533	0.0429	CbGeAlD
Indomethacin—ABCC11—embryo—amyotrophic lateral sclerosis	0.00527	0.0425	CbGeAlD
Indomethacin—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00525	0.0184	CcSEcCtD
Indomethacin—Ileus—Riluzole—amyotrophic lateral sclerosis	0.0052	0.0182	CcSEcCtD
Indomethacin—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00515	0.0181	CcSEcCtD
Indomethacin—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.0051	0.0179	CcSEcCtD
Indomethacin—PPARG—appendage—amyotrophic lateral sclerosis	0.00473	0.0382	CbGeAlD
Indomethacin—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00454	0.0159	CcSEcCtD
Indomethacin—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00447	0.0157	CcSEcCtD
Indomethacin—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00434	0.0152	CcSEcCtD
Indomethacin—Gout—Riluzole—amyotrophic lateral sclerosis	0.00394	0.0138	CcSEcCtD
Indomethacin—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00389	0.0136	CcSEcCtD
Indomethacin—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00389	0.0136	CcSEcCtD
Indomethacin—PTGDR2—cerebellum—amyotrophic lateral sclerosis	0.00363	0.0292	CbGeAlD
Indomethacin—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00349	0.0122	CcSEcCtD
Indomethacin—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00345	0.0121	CcSEcCtD
Indomethacin—PTGR2—medulla oblongata—amyotrophic lateral sclerosis	0.0034	0.0274	CbGeAlD
Indomethacin—Coma—Riluzole—amyotrophic lateral sclerosis	0.00336	0.0118	CcSEcCtD
Indomethacin—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00333	0.0117	CcSEcCtD
Indomethacin—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00327	0.0115	CcSEcCtD
Indomethacin—PTGR2—spinal cord—amyotrophic lateral sclerosis	0.00304	0.0245	CbGeAlD
Indomethacin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00299	0.0105	CcSEcCtD
Indomethacin—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00299	0.0105	CcSEcCtD
Indomethacin—PTGDR2—brain—amyotrophic lateral sclerosis	0.00295	0.0237	CbGeAlD
Indomethacin—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00294	0.0103	CcSEcCtD
Indomethacin—PPARA—embryo—amyotrophic lateral sclerosis	0.00286	0.023	CbGeAlD
Indomethacin—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00993	CcSEcCtD
Indomethacin—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.00282	0.0227	CbGeAlD
Indomethacin—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00972	CcSEcCtD
Indomethacin—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00268	0.0094	CcSEcCtD
Indomethacin—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00937	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00937	CcSEcCtD
Indomethacin—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00937	CcSEcCtD
Indomethacin—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00915	CcSEcCtD
Indomethacin—PTGR2—nervous system—amyotrophic lateral sclerosis	0.00256	0.0206	CbGeAlD
Indomethacin—PTGR2—central nervous system—amyotrophic lateral sclerosis	0.00246	0.0199	CbGeAlD
Indomethacin—PTGS2—appendage—amyotrophic lateral sclerosis	0.00242	0.0195	CbGeAlD
Indomethacin—PTGR2—cerebellum—amyotrophic lateral sclerosis	0.00241	0.0194	CbGeAlD
Indomethacin—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00829	CcSEcCtD
Indomethacin—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00826	CcSEcCtD
Indomethacin—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00815	CcSEcCtD
Indomethacin—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00809	CcSEcCtD
Indomethacin—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00776	CcSEcCtD
Indomethacin—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00769	CcSEcCtD
Indomethacin—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00748	CcSEcCtD
Indomethacin—GLO1—medulla oblongata—amyotrophic lateral sclerosis	0.0021	0.017	CbGeAlD
Indomethacin—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00737	CcSEcCtD
Indomethacin—Depression—Riluzole—amyotrophic lateral sclerosis	0.00205	0.0072	CcSEcCtD
Indomethacin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00707	CcSEcCtD
Indomethacin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00703	CcSEcCtD
Indomethacin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00703	CcSEcCtD
Indomethacin—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00692	CcSEcCtD
Indomethacin—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00688	CcSEcCtD
Indomethacin—PTGR2—brain—amyotrophic lateral sclerosis	0.00196	0.0158	CbGeAlD
Indomethacin—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00681	CcSEcCtD
Indomethacin—CXCL8—medulla oblongata—amyotrophic lateral sclerosis	0.00194	0.0156	CbGeAlD
Indomethacin—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00674	CcSEcCtD
Indomethacin—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0066	CcSEcCtD
Indomethacin—GLO1—spinal cord—amyotrophic lateral sclerosis	0.00188	0.0151	CbGeAlD
Indomethacin—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00651	CcSEcCtD
Indomethacin—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00648	CcSEcCtD
Indomethacin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00648	CcSEcCtD
Indomethacin—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00613	CcSEcCtD
Indomethacin—CXCL8—spinal cord—amyotrophic lateral sclerosis	0.00173	0.0139	CbGeAlD
Indomethacin—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00579	CcSEcCtD
Indomethacin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00573	CcSEcCtD
Indomethacin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00556	CcSEcCtD
Indomethacin—GLO1—nervous system—amyotrophic lateral sclerosis	0.00158	0.0127	CbGeAlD
Indomethacin—Tension—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00553	CcSEcCtD
Indomethacin—PPARG—embryo—amyotrophic lateral sclerosis	0.00157	0.0127	CbGeAlD
Indomethacin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00548	CcSEcCtD
Indomethacin—GLO1—central nervous system—amyotrophic lateral sclerosis	0.00152	0.0123	CbGeAlD
Indomethacin—AKR1C3—medulla oblongata—amyotrophic lateral sclerosis	0.00152	0.0122	CbGeAlD
Indomethacin—Bromfenac—PTGS2—amyotrophic lateral sclerosis	0.00151	0.459	CrCbGaD
Indomethacin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00523	CcSEcCtD
Indomethacin—GLO1—cerebellum—amyotrophic lateral sclerosis	0.00149	0.012	CbGeAlD
Indomethacin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00521	CcSEcCtD
Indomethacin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00515	CcSEcCtD
Indomethacin—PLA2G2A—nervous system—amyotrophic lateral sclerosis	0.00147	0.0118	CbGeAlD
Indomethacin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00509	CcSEcCtD
Indomethacin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00507	CcSEcCtD
Indomethacin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00506	CcSEcCtD
Indomethacin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00505	CcSEcCtD
Indomethacin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00498	CcSEcCtD
Indomethacin—PLA2G2A—central nervous system—amyotrophic lateral sclerosis	0.00141	0.0114	CbGeAlD
Indomethacin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00496	CcSEcCtD
Indomethacin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00489	CcSEcCtD
Indomethacin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00487	CcSEcCtD
Indomethacin—PPARA—nervous system—amyotrophic lateral sclerosis	0.00137	0.0111	CbGeAlD
Indomethacin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00137	0.0048	CcSEcCtD
Indomethacin—CXCL8—cerebellum—amyotrophic lateral sclerosis	0.00137	0.011	CbGeAlD
Indomethacin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00479	CcSEcCtD
Indomethacin—AKR1C3—spinal cord—amyotrophic lateral sclerosis	0.00135	0.0109	CbGeAlD
Indomethacin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00474	CcSEcCtD
Indomethacin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00464	CcSEcCtD
Indomethacin—PPARA—central nervous system—amyotrophic lateral sclerosis	0.00132	0.0106	CbGeAlD
Indomethacin—SLC10A1—nervous system—amyotrophic lateral sclerosis	0.00132	0.0106	CbGeAlD
Indomethacin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0046	CcSEcCtD
Indomethacin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0046	CcSEcCtD
Indomethacin—Shock—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00453	CcSEcCtD
Indomethacin—PPARA—cerebellum—amyotrophic lateral sclerosis	0.00129	0.0104	CbGeAlD
Indomethacin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00451	CcSEcCtD
Indomethacin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00449	CcSEcCtD
Indomethacin—SLC10A1—central nervous system—amyotrophic lateral sclerosis	0.00127	0.0102	CbGeAlD
Indomethacin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00445	CcSEcCtD
Indomethacin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00439	CcSEcCtD
Indomethacin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0043	CcSEcCtD
Indomethacin—GLO1—brain—amyotrophic lateral sclerosis	0.00121	0.00974	CbGeAlD
Indomethacin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00416	CcSEcCtD
Indomethacin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00413	CcSEcCtD
Indomethacin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00117	0.0041	CcSEcCtD
Indomethacin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00409	CcSEcCtD
Indomethacin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00405	CcSEcCtD
Indomethacin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00114	0.004	CcSEcCtD
Indomethacin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00397	CcSEcCtD
Indomethacin—PLA2G2A—brain—amyotrophic lateral sclerosis	0.00112	0.00905	CbGeAlD
Indomethacin—Pain—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00394	CcSEcCtD
Indomethacin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00394	CcSEcCtD
Indomethacin—CXCL8—brain—amyotrophic lateral sclerosis	0.00111	0.00896	CbGeAlD
Indomethacin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00379	CcSEcCtD
Indomethacin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00376	CcSEcCtD
Indomethacin—AKR1C3—cerebellum—amyotrophic lateral sclerosis	0.00107	0.00865	CbGeAlD
Indomethacin—PPARA—brain—amyotrophic lateral sclerosis	0.00105	0.00845	CbGeAlD
Indomethacin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00366	CcSEcCtD
Indomethacin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00364	CcSEcCtD
Indomethacin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00364	CcSEcCtD
Indomethacin—CES1—nervous system—amyotrophic lateral sclerosis	0.00102	0.00821	CbGeAlD
Indomethacin—Tolmetin—PTGS2—amyotrophic lateral sclerosis	0.00102	0.309	CrCbGaD
Indomethacin—SLC10A1—brain—amyotrophic lateral sclerosis	0.00101	0.00813	CbGeAlD
Indomethacin—CES1—central nervous system—amyotrophic lateral sclerosis	0.00098	0.0079	CbGeAlD
Indomethacin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000967	0.00339	CcSEcCtD
Indomethacin—SLCO1A2—medulla oblongata—amyotrophic lateral sclerosis	0.000948	0.00764	CbGeAlD
Indomethacin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000942	0.0033	CcSEcCtD
Indomethacin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000929	0.00326	CcSEcCtD
Indomethacin—SLC22A7—brain—amyotrophic lateral sclerosis	0.000899	0.00725	CbGeAlD
Indomethacin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000898	0.00315	CcSEcCtD
Indomethacin—AKR1C3—brain—amyotrophic lateral sclerosis	0.000871	0.00702	CbGeAlD
Indomethacin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000868	0.00304	CcSEcCtD
Indomethacin—SLC22A6—brain—amyotrophic lateral sclerosis	0.000868	0.007	CbGeAlD
Indomethacin—SLCO1A2—spinal cord—amyotrophic lateral sclerosis	0.000845	0.00681	CbGeAlD
Indomethacin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000835	0.00293	CcSEcCtD
Indomethacin—ABCC3—nervous system—amyotrophic lateral sclerosis	0.00083	0.00669	CbGeAlD
Indomethacin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000828	0.0029	CcSEcCtD
Indomethacin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000827	0.0029	CcSEcCtD
Indomethacin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000822	0.00288	CcSEcCtD
Indomethacin—PTGS2—embryo—amyotrophic lateral sclerosis	0.000803	0.00647	CbGeAlD
Indomethacin—ABCC3—central nervous system—amyotrophic lateral sclerosis	0.000799	0.00644	CbGeAlD
Indomethacin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00078	0.00273	CcSEcCtD
Indomethacin—CES1—brain—amyotrophic lateral sclerosis	0.000778	0.00627	CbGeAlD
Indomethacin—Naproxen—PTGS2—amyotrophic lateral sclerosis	0.000765	0.232	CrCbGaD
Indomethacin—PPARG—nervous system—amyotrophic lateral sclerosis	0.000755	0.00608	CbGeAlD
Indomethacin—PPARG—central nervous system—amyotrophic lateral sclerosis	0.000727	0.00586	CbGeAlD
Indomethacin—SLCO1A2—nervous system—amyotrophic lateral sclerosis	0.000712	0.00574	CbGeAlD
Indomethacin—SLCO1A2—central nervous system—amyotrophic lateral sclerosis	0.000686	0.00553	CbGeAlD
Indomethacin—ABCC4—nervous system—amyotrophic lateral sclerosis	0.000685	0.00552	CbGeAlD
Indomethacin—SLC22A8—nervous system—amyotrophic lateral sclerosis	0.00068	0.00548	CbGeAlD
Indomethacin—SLCO1A2—cerebellum—amyotrophic lateral sclerosis	0.00067	0.0054	CbGeAlD
Indomethacin—ABCC4—central nervous system—amyotrophic lateral sclerosis	0.00066	0.00532	CbGeAlD
Indomethacin—SLC22A8—central nervous system—amyotrophic lateral sclerosis	0.000655	0.00528	CbGeAlD
Indomethacin—ABCC3—brain—amyotrophic lateral sclerosis	0.000635	0.00511	CbGeAlD
Indomethacin—PPARG—brain—amyotrophic lateral sclerosis	0.000577	0.00465	CbGeAlD
Indomethacin—ABCC1—cerebellum—amyotrophic lateral sclerosis	0.00055	0.00443	CbGeAlD
Indomethacin—SLCO1A2—brain—amyotrophic lateral sclerosis	0.000544	0.00439	CbGeAlD
Indomethacin—ALB—brain—amyotrophic lateral sclerosis	0.000541	0.00436	CbGeAlD
Indomethacin—ABCC4—brain—amyotrophic lateral sclerosis	0.000524	0.00422	CbGeAlD
Indomethacin—SLC22A8—brain—amyotrophic lateral sclerosis	0.00052	0.00419	CbGeAlD
Indomethacin—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.000513	0.00414	CbGeAlD
Indomethacin—ABCB1—embryo—amyotrophic lateral sclerosis	0.000497	0.004	CbGeAlD
Indomethacin—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.000479	0.00386	CbGeAlD
Indomethacin—PTGS2—spinal cord—amyotrophic lateral sclerosis	0.000458	0.00369	CbGeAlD
Indomethacin—ABCC1—brain—amyotrophic lateral sclerosis	0.000447	0.0036	CbGeAlD
Indomethacin—PTGS1—nervous system—amyotrophic lateral sclerosis	0.000403	0.00325	CbGeAlD
Indomethacin—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.000388	0.00313	CbGeAlD
Indomethacin—PTGS2—nervous system—amyotrophic lateral sclerosis	0.000386	0.00311	CbGeAlD
Indomethacin—PTGS2—central nervous system—amyotrophic lateral sclerosis	0.000371	0.00299	CbGeAlD
Indomethacin—PTGS2—cerebellum—amyotrophic lateral sclerosis	0.000363	0.00292	CbGeAlD
Indomethacin—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000317	0.00256	CbGeAlD
Indomethacin—PTGS1—brain—amyotrophic lateral sclerosis	0.000308	0.00249	CbGeAlD
Indomethacin—PTGS2—brain—amyotrophic lateral sclerosis	0.000295	0.00238	CbGeAlD
Indomethacin—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000283	0.00228	CbGeAlD
Indomethacin—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000239	0.00192	CbGeAlD
Indomethacin—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.00023	0.00185	CbGeAlD
Indomethacin—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000224	0.00181	CbGeAlD
Indomethacin—ABCB1—brain—amyotrophic lateral sclerosis	0.000182	0.00147	CbGeAlD
Indomethacin—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	5.59e-05	0.000251	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.59e-05	0.000251	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	5.57e-05	0.000251	CbGpPWpGaD
Indomethacin—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	5.54e-05	0.000249	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	5.53e-05	0.000249	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.53e-05	0.000248	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—CHAT—amyotrophic lateral sclerosis	5.5e-05	0.000248	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—CHAT—amyotrophic lateral sclerosis	5.5e-05	0.000248	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	5.45e-05	0.000245	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—GSR—amyotrophic lateral sclerosis	5.45e-05	0.000245	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—GSR—amyotrophic lateral sclerosis	5.45e-05	0.000245	CbGpPWpGaD
Indomethacin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	5.43e-05	0.000244	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	5.41e-05	0.000243	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.32e-05	0.000239	CbGpPWpGaD
Indomethacin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	5.28e-05	0.000237	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.26e-05	0.000236	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—ERBB4—amyotrophic lateral sclerosis	5.25e-05	0.000236	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—GSR—amyotrophic lateral sclerosis	5.25e-05	0.000236	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.24e-05	0.000236	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.24e-05	0.000235	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	5.23e-05	0.000235	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—CHAT—amyotrophic lateral sclerosis	5.21e-05	0.000234	CbGpPWpGaD
Indomethacin—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	5.16e-05	0.000232	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.15e-05	0.000232	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	5.06e-05	0.000228	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	5.06e-05	0.000228	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	5.04e-05	0.000227	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	5.04e-05	0.000227	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.02e-05	0.000226	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5e-05	0.000225	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5e-05	0.000225	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	4.99e-05	0.000224	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.96e-05	0.000223	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.94e-05	0.000222	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.94e-05	0.000222	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	4.9e-05	0.000221	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	4.88e-05	0.00022	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.81e-05	0.000216	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.81e-05	0.000216	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.81e-05	0.000216	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.8e-05	0.000216	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.79e-05	0.000216	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.78e-05	0.000215	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.76e-05	0.000214	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.75e-05	0.000214	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.72e-05	0.000212	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—APOE—amyotrophic lateral sclerosis	4.66e-05	0.000209	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	4.63e-05	0.000208	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.62e-05	0.000208	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	4.62e-05	0.000208	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	4.62e-05	0.000208	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	4.56e-05	0.000205	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.55e-05	0.000204	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	4.55e-05	0.000204	CbGpPWpGaD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.54e-05	0.000204	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.52e-05	0.000203	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.51e-05	0.000203	CbGpPWpGaD
Indomethacin—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	4.51e-05	0.000203	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.5e-05	0.000202	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.5e-05	0.000202	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CHAT—amyotrophic lateral sclerosis	4.47e-05	0.000201	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.47e-05	0.000201	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—MMP9—amyotrophic lateral sclerosis	4.46e-05	0.000201	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.46e-05	0.0002	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	4.45e-05	0.0002	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	4.44e-05	0.0002	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.38e-05	0.000197	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.38e-05	0.000197	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.37e-05	0.000197	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CST3—amyotrophic lateral sclerosis	4.35e-05	0.000195	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.31e-05	0.000194	CbGpPWpGaD
Indomethacin—CXCL8—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	4.31e-05	0.000194	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.3e-05	0.000194	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.3e-05	0.000194	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.3e-05	0.000193	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.29e-05	0.000193	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	4.22e-05	0.00019	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.2e-05	0.000189	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.14e-05	0.000186	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	4.1e-05	0.000184	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.08e-05	0.000184	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.08e-05	0.000184	CbGpPWpGaD
Indomethacin—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	4.08e-05	0.000183	CbGpPWpGaD
Indomethacin—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	4.07e-05	0.000183	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—APOE—amyotrophic lateral sclerosis	4.06e-05	0.000183	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	4.05e-05	0.000182	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.04e-05	0.000182	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	4.02e-05	0.000181	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	4.01e-05	0.00018	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—APOE—amyotrophic lateral sclerosis	3.96e-05	0.000178	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.95e-05	0.000178	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.94e-05	0.000177	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.93e-05	0.000177	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.9e-05	0.000176	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.9e-05	0.000176	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.82e-05	0.000172	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.8e-05	0.000171	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	3.79e-05	0.000171	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	3.76e-05	0.000169	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.74e-05	0.000168	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	3.71e-05	0.000167	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	3.69e-05	0.000166	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.68e-05	0.000165	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.67e-05	0.000165	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	3.66e-05	0.000165	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.65e-05	0.000164	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.59e-05	0.000161	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	3.57e-05	0.000161	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.56e-05	0.00016	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	3.52e-05	0.000159	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.46e-05	0.000156	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.46e-05	0.000156	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.44e-05	0.000155	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.41e-05	0.000154	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—APOE—amyotrophic lateral sclerosis	3.4e-05	0.000153	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.39e-05	0.000152	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	3.34e-05	0.00015	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.33e-05	0.00015	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.25e-05	0.000146	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.21e-05	0.000144	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.2e-05	0.000144	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.19e-05	0.000143	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	3.18e-05	0.000143	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CASP9—amyotrophic lateral sclerosis	3.16e-05	0.000142	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.11e-05	0.00014	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	3.09e-05	0.000139	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	3.07e-05	0.000138	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.06e-05	0.000137	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3e-05	0.000135	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.96e-05	0.000133	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.96e-05	0.000133	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—APOE—amyotrophic lateral sclerosis	2.95e-05	0.000133	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	2.92e-05	0.000131	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.9e-05	0.000131	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.89e-05	0.00013	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.87e-05	0.000129	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	2.85e-05	0.000128	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.85e-05	0.000128	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	2.85e-05	0.000128	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.85e-05	0.000128	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.8e-05	0.000126	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.8e-05	0.000126	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.8e-05	0.000126	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PTGS2—amyotrophic lateral sclerosis	2.79e-05	0.000125	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	2.77e-05	0.000125	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.73e-05	0.000123	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.72e-05	0.000122	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.72e-05	0.000122	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.71e-05	0.000122	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.71e-05	0.000122	CbGpPWpGaD
Indomethacin—ABCC1—Disease—ERBB4—amyotrophic lateral sclerosis	2.71e-05	0.000122	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.7e-05	0.000121	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.64e-05	0.000119	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.6e-05	0.000117	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.58e-05	0.000116	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.58e-05	0.000116	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.57e-05	0.000116	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.56e-05	0.000115	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	2.56e-05	0.000115	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	2.53e-05	0.000114	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	2.5e-05	0.000112	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.46e-05	0.000111	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	2.42e-05	0.000109	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.41e-05	0.000108	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.4e-05	0.000108	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.4e-05	0.000108	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.37e-05	0.000106	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.35e-05	0.000106	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.35e-05	0.000106	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	2.34e-05	0.000105	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	2.33e-05	0.000105	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.33e-05	0.000105	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.33e-05	0.000105	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.32e-05	0.000104	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.28e-05	0.000103	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.25e-05	0.000101	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—APOE—amyotrophic lateral sclerosis	2.24e-05	0.000101	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—APOE—amyotrophic lateral sclerosis	2.24e-05	0.000101	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.21e-05	9.93e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.21e-05	9.93e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.2e-05	9.91e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.14e-05	9.61e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.13e-05	9.58e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.13e-05	9.56e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	2.12e-05	9.54e-05	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	2.12e-05	9.51e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—APOE—amyotrophic lateral sclerosis	2.12e-05	9.51e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	2.1e-05	9.45e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—APOE—amyotrophic lateral sclerosis	2.09e-05	9.41e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.05e-05	9.23e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.02e-05	9.1e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.02e-05	9.09e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.96e-05	8.81e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.95e-05	8.76e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.94e-05	8.72e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.92e-05	8.63e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.92e-05	8.62e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.86e-05	8.34e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.83e-05	8.22e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—APOE—amyotrophic lateral sclerosis	1.82e-05	8.17e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.82e-05	8.17e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	1.82e-05	8.17e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.81e-05	8.14e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.8e-05	8.1e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—APOE—amyotrophic lateral sclerosis	1.75e-05	7.88e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.75e-05	7.87e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.71e-05	7.69e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	1.67e-05	7.49e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.56e-05	7e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.54e-05	6.91e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.53e-05	6.89e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.53e-05	6.89e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	1.48e-05	6.66e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.46e-05	6.58e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.45e-05	6.52e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—amyotrophic lateral sclerosis	1.43e-05	6.45e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.43e-05	6.43e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.43e-05	6.42e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	1.4e-05	6.32e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.35e-05	6.07e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.33e-05	6e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.31e-05	5.91e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.27e-05	5.7e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.26e-05	5.66e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.25e-05	5.6e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.25e-05	5.6e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.21e-05	5.45e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.2e-05	5.4e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.2e-05	5.39e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	1.18e-05	5.29e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.16e-05	5.22e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.16e-05	5.2e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.14e-05	5.13e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.13e-05	5.08e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.1e-05	4.96e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.04e-05	4.67e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.03e-05	4.63e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.02e-05	4.57e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.01e-05	4.56e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	9.57e-06	4.3e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	9.52e-06	4.28e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.47e-06	4.26e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.16e-06	4.12e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	8.54e-06	3.84e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	8.34e-06	3.75e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	7.79e-06	3.5e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.52e-06	2.93e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.85e-06	2.63e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.71e-06	2.57e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.34e-06	2.4e-05	CbGpPWpGaD
